2017

---Ankebio start clinical study phase Ⅲ of Recombinant Human HER2 moloclonal antibody drug for Injection

---Construction of key laboratory of genetic engineering pharmacy in Anhui Province was approved

---Ankebio's production application of Growth hormone liquid for injection was accepted

---PersonGen Anke's CAR-T application for clinical trials of new drugs was accepted

---Anhui Anke Hengyi Pharmaceutical co.,Ltd received the notice of drug registration acceptance

---Anterferon passes review of Anhui province famous brand product

---Ankebio and its two subsidiaries were recognized as high-tech enterprises

---Ankebio's a preparation method of high purity Recombinant human interferon Alpha 2b and a method for the preparation of high purity tenofovir dipifuroxime fumarate" have obtained national invention patent


2016

---Ankebio formally established the translational medicine center

---Ankebio holds a precision medicine seminar

---An academician workstation of Ankebio has been approved

---Ankebio successfully developed an anti-cancer drug recombinant human HER2 monoclonal antibody drug

---Ankebio accepts pd-1 humanized antibodies and related technologies

---"A type of Recombinant human interferon alpha 2b formulation" was awarded China patent excellence award and the fourth Anhui patent gold award

---First listed in the "top ten companies of China's GEM"

---160th anniversary of Anhui Anke Yuliangqing Pharmaceutical Co.,Ltd

---Anhui Anke Hengyi Pharmaceutical co.,Ltd was recognized as a national high-tech enterprise

---10th anniversary of AGCU ScienTech Incorporation

---Important progress has been made by PersonGen Biomedicine (suzhou) co. LTD in the treatment of T-cell lymphoma

---CAR-T therapy of PersonGen Anke was initially successful

---Ankebio holds the first Open Day event for employee family

2015

---Ankebio wholly purchased Shanghai Soho-YiMing pharmaceuticals co. LTD

---Ankebio participation PersonGen Biomedicine (suzhou) co. LTD

---The wholly-owned subsidiary Anhui Anke YuLiangQing Pharmaceutical co.,ltd passed the national high and new technology enterprise recognition smoothly.

---Anke trademark has been identified as "well-known trademark of China".

---Ankebio's board won the title of "outstanding board of directors of China's gem listed companies in 2015"

---Ankebio again won the title of "tax credit grade A" enterprise

---"A kind of recombinant human interferon Alpha 2b formulation" won the fourth anhui province patent gold award

2014

---Clinical research on growth hormone replacement therapy for adult growth hormone deficiency is initiated

---Ankebio holdings established Anhui xinhuakun biotechnology co., LTD., and introduced the national new biological product KGF-2 project

---Ankebio won the award of Third Anhui patent

2013

---Chairman Song lihua was elected as a deputy to the 12th NPC

---The 20th anniversary celebration of Ankebio was successfully held

---The two development projects of long-term pegylated recombinant protein drug undertaken by anke biological have been accepted

---Ankebio recombinant human growth hormone injection obtained the invention patent

2012

---Ankebio was identified as a national innovative pilot enterprise

---Ankebio has been formally certified by iso 9001:2008

2011

---The project of "The development of antibody diagnostic and therapeutic drugs targeted at tumor marker p185/ErbB2 '' won the third prize of Anhui Province Science and Technology Award.

---Ankebio was rated as anhui province A - grade tax credit unit

2010

---Ankebio was identified as "anhui province joint demonstration enterprise of production, education and research"

2009

---Ankebio became the first batch of Chinese Second-board Market listed companies.

2006

---Our Ansomone® / Recombianant Human Growth Hormone was granted "The Famous Reliable Brand of Anhui Province" by Anhui Bureau of Quality and Technical Supervision associated with Anhui Promotion of Famous Brands Committer.
2001

--- Our Anterferon® / Recombianant Human Interferon a 2b was granted "The Famous Reliable Brand of Anhui Province" by Anhui Bureau of Quality and Technical Supervision associated with Anhui Promotion of Famous Brands Committer.

2000

--- Our Anterferon® / Recombianant Human Interferon a 2b for Injection granted the Certificate of National New Drugs.

--- Our Anterferon® / Recombinant Human Interferon a 2b for Injection was approved for mass production.

---won the Special Prize of Science and Technology by Anhui Provincal Government.

--- won First Prize in the Development of Technological Prize by Anhui Provincal Government.

--- Our Anterferon® / Recombinant Human Interferon a 2b Cream won IV-Class Certificate of National Novel Drugs awarded by Administration of Drugs Supervision.

1999

--- The manufacturing plants of Anterferon® / Recombinant Human Interferon a 2b  was approved by sFDA with GMP Certificate.

--- The manufacturing plants of Ansomone® / Recombination Human Growth Hormone was approved by sFDA with GMP Certificate.

--- Ansomone® / Recombinant Human Growth Hormone Project was approved and supported in China National Invention Funds Project

1998

--- Anterferon® / Recombinant Human Interferon a 2b for Injection is granted the Certificate of National Key Novel Products and was approved and supported by China National Key Torch Project.

1997

--- Anterferon ® / Recombination Human Interferon a 2b for injection was granted the certificate of  National Novel Drugs and document of producing ratification (China II Class New Drug ).

---was awarded the prize of Development of technological Prize, III-Class by Anhui Provincial Government.

1996

---Monoclonal Antibody Affinity Gel to a-interferon was granted the Certificate of National Novel Product.

1995

---The study and application of Monoclonal Antibody Human Interferon a- was awarded andby Anhui Provincial Government.

1994

----The study and application of Monoclonal Antibody Human Interferon a was awarded.


Top
搯钱树水心论坛黄大仙